The BRAF V600E mutation in papillary thyroid carcinoma (PTC) is linked to aggressive behavior and frequent occult central lymph node metastases (CLNM), posing a surgical dilemma in clinically node-negative (cN0) patients. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.